Abstract
The immunotoxic potential of ENU, a potent and transplacental neurocarcinogen, was evaluated in male CD1 mice. The animals received i.p. injections of ENU--0, 2, 8 or 32 mg/kg body weight, in citrate-phosphate buffer, twice weekly for three weeks. Splenic lymphocytes were cultured in the presence of mitogens, lipopolysaccharide, pokeweed mitogen, concanavalin A and phytohaemagglutinin. Mixed lymphocyte cultures in the presence of allogeneic cells were also tested. Blastogenic response decreased in a dose-dependent manner, as measured by the 3H-thymidine uptake by splenocytes. Primary antibody production by splenic lymphocytes from animals challenged with a T-dependent antigen (sheep red blood cells) was stimulated at low doses but depressed at the highest dose group compared with the controls, whereas T-independent cell response showed no significant change. Our results suggest that exposure to repeated, low levels of ENU significantly alters the immune status of CD1 mice. The effects appear to be somewhat selective to T cell processes, based on in vivo responses to T-dependent and T-independent antigens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Busbee D. L., Joe C. O., Rankin P. W., Ziprin R. L., Wilson R. D. Benzo[a]pyrene uptake by lymph: a possible transport mode for immunosuppressive chemicals. J Toxicol Environ Health. 1984;13(1):43–51. doi: 10.1080/15287398409530480. [DOI] [PubMed] [Google Scholar]
- Cunningham A. J., Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 1968 Apr;14(4):599–600. [PMC free article] [PubMed] [Google Scholar]
- Dean J. H., Ward E. C., Murray M. J., Lauer L. D., House R. V. Mechanisms of dimethylbenzanthracene-induced immunotoxicity. Clin Physiol Biochem. 1985;3(2-3):98–110. [PubMed] [Google Scholar]
- Goth R., Rajewsky M. F. Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci U S A. 1974 Mar;71(3):639–643. doi: 10.1073/pnas.71.3.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris G., Lawley P. D., Asbery L. J., Chandler P. M., Jones M. G. Autoimmune haemolytic disease in mice after exposure to a methylating carcinogen. Immunology. 1983 Jul;49(3):439–449. [PMC free article] [PubMed] [Google Scholar]
- Luster M. I., Dean J. H., Boorman G. A., Dieter M. P., Hayes H. T. Immune functions in methyl and ethyl carbamate treated mice. Clin Exp Immunol. 1982 Oct;50(1):223–230. [PMC free article] [PubMed] [Google Scholar]
- Reddy R. V., Taylor M. J., Sharma R. P. Studies of immune function of CD-1 mice exposed to aflatoxin B1. Toxicology. 1987 Feb;43(2):123–132. doi: 10.1016/0300-483x(87)90002-3. [DOI] [PubMed] [Google Scholar]
- Stoica G., Koestner A. Diverse spectrum of tumors in male Sprague-Dawley rats following single high doses of N-ethyl-N-nitrosourea (ENU). Am J Pathol. 1984 Aug;116(2):319–326. [PMC free article] [PubMed] [Google Scholar]
- Urso P., Gengozian N. Alterations in the humoral immune response and tumor frequencies in mice exposed to benzo[a]pyrene and X-rays before or after birth. J Toxicol Environ Health. 1982 Oct-Nov;10(4-5):817–835. doi: 10.1080/15287398209530297. [DOI] [PubMed] [Google Scholar]
- Vesselinovitch S. D., Rao K. V., Mihailovich N., Rice J. M., Lombard L. S. Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain. Cancer Res. 1974 Oct;34(10):2530–2538. [PubMed] [Google Scholar]
- Ward E. C., Murray M. J., Lauer L. D., House R. V., Irons R., Dean J. H. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance. Toxicol Appl Pharmacol. 1984 Sep 15;75(2):299–308. doi: 10.1016/0041-008x(84)90212-6. [DOI] [PubMed] [Google Scholar]